3,766
Views
28
CrossRef citations to date
0
Altmetric
Haematological malignancies

Treatment outcome in T-cell lymphoblastic lymphoma in adults – a population-based study from the Swedish Lymphoma Registry

, , &
Pages 927-934 | Received 14 Jul 2013, Accepted 24 Jan 2014, Published online: 10 Mar 2014

References

  • Brunning RD, Borowitz M, Matutes E, Head D, Flandrin G, Swerdlow SH, et al. Precursor T lymphoblastic leukaemia/lymphoblastic lymphoma. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. World Health Organization. International Agency for Research on Cancer. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2001. p 115–7.
  • Callens C, Baleydier F, Lengline E, Ben Abdelali R, Petit A, Villarese P, et al. Clinical impact of NOTCH1 and/or FBXW7 mutations, FLASH deletion, and TCR status in pediatric T-cell lymphoblastic lymphoma. J Clin Oncol 2012; 30:1966–73.
  • Raetz EA, Perkins SL, Bhojwani D, Smock K, Philip M, Carroll WL, et al. Gene expression profiling reveals intrinsic differences between T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma. Pediatr Blood Cancer 2006; 47:130–40.
  • Sekimizu M, Sunami S, Nakazawa A, Hayashi Y, Okimoto Y, Saito AM, et al. Chromosome abnormalities in advanced stage T-cell lymphoblastic lymphoma of children and adolescents: A report from Japanese Paediatric Leukaemia/ Lymphoma Study Group (JPLSG) and review of the literature. Br J Haematol 2011;154:612–7.
  • Nathwani BN, Diamond LW, Winberg CD, Kim H, Bearman RM, Glick JH, et al. Lymphoblastic lymphoma: A clinicopathologic study of 95 patients. Cancer 1981;48: 2347–57.
  • Reiter A, Schrappe M, Ludwig WD, Tiemann M, Parwaresch R, Zimmermann M, et al. Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: A BFM group report. Blood 2000;95:416–21.
  • Song KW, Barnett MJ, Gascoyne RD, Chhanabhai M, Forrest DL, Hogge DE, et al. Primary therapy for adults with T-cell lymphoblastic lymphoma with hematopoietic stem-cell transplantation results in favorable outcomes. Ann Oncol 2007;18:535–40.
  • Sweetenham JW, Santini G, Qian W, Guelfi M, Schmitz N, Simnett S, et al. High-dose therapy and autologous stem-cell transplantation versus conventional-dose consolidation/maintenance therapy as postremission therapy for adult patients with lymphoblastic lymphoma: Results of a randomized trial of the European Group for Blood and Marrow Transplantation and the United Kingdom Lymphoma Group. J Clin Oncol 2001;19:2927–36.
  • Levine JE, Harris RE, Loberiza FR, Jr., Armitage JO, Vose JM, Van Besien K, et al. A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma. Blood 2003;101:2476–82.
  • Hoelzer D, Gokbuget N, Digel W, Faak T, Kneba M, Reutzel R, et al. Outcome of adult patients with T-lymphoblastic lymphoma treated according to protocols for acute lymphoblastic leukemia. Blood 2002;99:4379–85.
  • Dabaja BS, Ha CS, Thomas DA, Wilder RB, Gopal R, Cortes J, et al. The role of local radiation therapy for mediastinal disease in adults with T-cell lymphoblastic lymphoma. Cancer 2002;94:2738–44.
  • Hunault M, Truchan-Graczyk M, Caillot D, Harousseau JL, Bologna S, Himberlin C, et al. Outcome of adult T-lymphoblastic lymphoma after acute lymphoblastic leukemia-type treatment: A GOELAMS trial. Haematologica 2007;92:1623–30.
  • Thomas DA, O’Brien S, Cortes J, Giles FJ, Faderl S, Verstovsek S, et al. Outcome with the hyper-CVAD regimens in lymphoblastic lymphoma. Blood 2004;104:1624–30.
  • Burkhardt B, Reiter A, Landmann E, Lang P, Lassay L, Dickerhoff R, et al. Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: A report from the berlin-frankfurt-muenster group. J Clin Oncol 2009;27:3363–9.
  • Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ, et al. Revised response criteria for malignant lymphoma. J Clin Oncol 2007;25:579–86.
  • Wollner N, Burchenal JH, Lieberman PH, Exelby P, D’Angio G, Murphy ML. Non-Hodgkin’s lymphoma in children. A comparative study of two modalities of therapy. Cancer 1976;37:123–34.
  • Gustafsson G, Schmiegelow K, Forestier E, Clausen N, Glomstein A, Jonmundsson G, et al. Improving outcome through two decades in childhood ALL in the Nordic countries: The impact of high-dose methotrexate in the reduction of CNS irradiation. Nordic Society of Pediatric Haematology and Oncology (NOPHO). Leukemia 2000;14:2267–75.
  • ClinicalTrials.gov [Internet]. Prednisolone or dexamethasone combined with chemotherapy in treating young patients with newly diagnosed lymphoblastic lymphoma. [cited 2013 April 15]. Available from: http://clinicaltrials.gov/
  • Bruggemann M, Raff T, Flohr T, Gokbuget N, Nakao M, Droese J, et al. Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia. Blood 2006;107:1116–23.
  • Kantarjian HM, O’Brien S, Smith TL, Cortes J, Giles FJ, Beran M, et al. Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia. J Clin Oncol 2000;18:547–61.
  • Hallbook H, Simonsson B, Ahlgren T, Bjorkholm M, Carneskog J, Grimfors G, et al. High-dose cytarabine in upfront therapy for adult patients with acute lymphoblastic leukaemia. Br J Haematol 2002;118:748–54.
  • Chang MH, Kim SJ, Kim K, Oh SY, Lee DH, Huh J, et al. Clinical features and treatment outcomes of adult B- and T-lymphoblastic lymphoma: Results of multicentre analysis in Korea. Leuk Lymphoma 2009;50:1119–25.
  • Lamvik J, Waage A, Wahl SG, Naess I, Paulsen PQ, Hammerstrom J. Adult acute lymphoblastic leukemia, Burkitt’s lymphoma and lymphoblastic lymphoma in middle Norway 1985–2004. Haematologica 2006;91:1428–9.
  • Suzumiya J, Ohshima K, Kikuchi M, Takeshita M, Akamatsu M, Tashiro K. Terminal deoxynucleotidyl transferase staining of malignant lymphomas in paraffin sections: A useful method for the diagnosis of lymphoblastic lymphoma. J Pathol 1997;182:86–91.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.